APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pipeline Embolization Device (PED)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pipeline Embolization Device (PED) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026196 pages

Choose your research edition.

Industry ResearchPipeline Embolization Device (PED) Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Pipeline Embolization Device (PED) Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pipeline Embolization Device (PED) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pipeline Embolization Device (PED) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pipeline Embolization Device (PED) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Pipeline Embolization Device (PED) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pipeline Embolization Device (PED) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pipeline Embolization Device (PED) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pipeline Embolization Device (PED) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pipeline Embolization Device (PED) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pipeline Embolization Device (PED) include Ascendis Health, Balt Extrusion, Boston Scientific, Codman, Evasc, Microvention, Phenox GmbH, Accumedical and ZYLOX-TONBRIDGE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pipeline Embolization Device (PED) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pipeline Embolization Device (PED) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pipeline Embolization Device (PED) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pipeline Embolization Device (PED) market size, projected growth trends, production technologies, key applications, and end-use industries.

Pipeline Embolization Device (PED) Segment by Company

Ascendis Health

Balt Extrusion

Boston Scientific

Codman

Evasc

Microvention

Phenox GmbH

Accumedical

ZYLOX-TONBRIDGE

Medtronic

Johnson & Johnson

Stryker Corporation

MicroPort

Pipeline Embolization Device (PED) Segment by Type

48 Alloy Wire Braided

64 Alloy Wire Braided

Other

Pipeline Embolization Device (PED) Segment by Application

Intracranial Aneurysm Treatment

Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)

Other

Pipeline Embolization Device (PED) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pipeline Embolization Device (PED) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pipeline Embolization Device (PED) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pipeline Embolization Device (PED).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pipeline Embolization Device (PED) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pipeline Embolization Device (PED) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pipeline Embolization Device (PED) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pipeline Embolization Device (PED) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pipeline Embolization Device (PED) Industry Trends Table 2. Pipeline Embolization Device (PED) Industry Drivers Table 3. Pipeline Embolization Device (PED) Industry Opportunities and Challenges Table 4. Pipeline Embolization Device (PED) Industry Restraints Table 5. Global Pipeline Embolization Device (PED) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pipeline Embolization Device (PED) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pipeline Embolization Device (PED) Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Pipeline Embolization Device (PED) Sales Market Share by Manufacturers Table 9. Global Pipeline Embolization Device (PED) Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Pipeline Embolization Device (PED) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pipeline Embolization Device (PED) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pipeline Embolization Device (PED) Manufacturers, Product Type & Application Table 13. Global Pipeline Embolization Device (PED) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pipeline Embolization Device (PED) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 48 Alloy Wire Braided Table 17. Major Manufacturers of 64 Alloy Wire Braided Table 18. Major Manufacturers of Other Table 19. Global Pipeline Embolization Device (PED) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (k units) Table 21. Global Pipeline Embolization Device (PED) Sales by Type (2027-2032) & (k units) Table 22. Global Pipeline Embolization Device (PED) Sales Market Share by Type (2021-2026) Table 23. Global Pipeline Embolization Device (PED) Sales Market Share by Type (2027-2032) Table 24. Global Pipeline Embolization Device (PED) Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Pipeline Embolization Device (PED) Revenue by Type (2021-2026) & (k units) Table 26. Global Pipeline Embolization Device (PED) Revenue by Type (2027-2032) & (k units) Table 27. Global Pipeline Embolization Device (PED) Revenue Market Share by Type (2021-2026) Table 28. Global Pipeline Embolization Device (PED) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Intracranial Aneurysm Treatment Table 30. Major Manufacturers of Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.) Table 31. Major Manufacturers of Other Table 32. Global Pipeline Embolization Device (PED) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (k units) Table 34. Global Pipeline Embolization Device (PED) Sales by Application (2027-2032) & (k units) Table 35. Global Pipeline Embolization Device (PED) Sales Market Share by Application (2021-2026) Table 36. Global Pipeline Embolization Device (PED) Sales Market Share by Application (2027-2032) Table 37. Global Pipeline Embolization Device (PED) Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Pipeline Embolization Device (PED) Revenue by Application (2021-2026) & (k units) Table 39. Global Pipeline Embolization Device (PED) Revenue by Application (2027-2032) & (k units) Table 40. Global Pipeline Embolization Device (PED) Revenue Market Share by Application (2021-2026) Table 41. Global Pipeline Embolization Device (PED) Revenue Market Share by Application (2027-2032) Table 42. Global Pipeline Embolization Device (PED) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Pipeline Embolization Device (PED) Sales by Region (2021-2026) & (k units) Table 44. Global Pipeline Embolization Device (PED) Sales Market Share by Region (2021-2026) Table 45. Global Pipeline Embolization Device (PED) Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Pipeline Embolization Device (PED) Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pipeline Embolization Device (PED) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Pipeline Embolization Device (PED) Sales by Country (2021-2026) & (k units) Table 49. North America Pipeline Embolization Device (PED) Sales by Country (2027-2032) & (k units) Table 50. Europe Pipeline Embolization Device (PED) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Pipeline Embolization Device (PED) Sales by Country (2021-2026) & (k units) Table 52. Europe Pipeline Embolization Device (PED) Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Pipeline Embolization Device (PED) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Pipeline Embolization Device (PED) Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Pipeline Embolization Device (PED) Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Pipeline Embolization Device (PED) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Pipeline Embolization Device (PED) Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Pipeline Embolization Device (PED) Sales by Country (2027-2032) & (k units) Table 59. Global Pipeline Embolization Device (PED) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pipeline Embolization Device (PED) Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pipeline Embolization Device (PED) Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pipeline Embolization Device (PED) Revenue Market Share by Region (2021-2026) Table 63. Global Pipeline Embolization Device (PED) Revenue Market Share by Region (2027-2032) Table 64. Ascendis Health Company Information Table 65. Ascendis Health Business Overview Table 66. Ascendis Health Pipeline Embolization Device (PED) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Ascendis Health Pipeline Embolization Device (PED) Product Portfolio Table 68. Ascendis Health Recent Development Table 69. Balt Extrusion Company Information Table 70. Balt Extrusion Business Overview Table 71. Balt Extrusion Pipeline Embolization Device (PED) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Balt Extrusion Pipeline Embolization Device (PED) Product Portfolio Table 73. Balt Extrusion Recent Development Table 74. Boston Scientific Company Information Table 75. Boston Scientific Business Overview Table 76. Boston Scientific Pipeline Embolization Device (PED) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Boston Scientific Pipeline Embolization Device (PED) Product Portfolio Table 78. Boston Scientific Recent Development Table 79. Codman Company Information Table 80. Codman Business Overview Table 81. Codman Pipeline Embolization Device (PED) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Codman Pipeline Embolization Device (PED) Product Portfolio Table 83. Codman Recent Development Table 84. Evasc Company Information Table 85. Evasc Business Overview Table 86. Evasc Pipeline Embolization Device (PED) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Evasc Pipeline Embolization Device (PED) Product Portfolio Table 88. Evasc Recent Development Table 89. Microvention Company Information Table 90. Microvention Business Overview Table 91. Microvention Pipeline Embolization Device (PED) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Microvention Pipeline Embolization Device (PED) Product Portfolio Table 93. Microvention Recent Development Table 94. Phenox GmbH Company Information Table 95. Phenox GmbH Business Overview Table 96. Phenox GmbH Pipeline Embolization Device (PED) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Phenox GmbH Pipeline Embolization Device (PED) Product Portfolio Table 98. Phenox GmbH Recent Development Table 99. Accumedical Company Information Table 100. Accumedical Business Overview Table 101. Accumedical Pipeline Embolization Device (PED) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Accumedical Pipeline Embolization Device (PED) Product Portfolio Table 103. Accumedical Recent Development Table 104. ZYLOX-TONBRIDGE Company Information Table 105. ZYLOX-TONBRIDGE Business Overview Table 106. ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Product Portfolio Table 108. ZYLOX-TONBRIDGE Recent Development Table 109. Medtronic Company Information Table 110. Medtronic Business Overview Table 111. Medtronic Pipeline Embolization Device (PED) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Medtronic Pipeline Embolization Device (PED) Product Portfolio Table 113. Medtronic Recent Development Table 114. Johnson & Johnson Company Information Table 115. Johnson & Johnson Business Overview Table 116. Johnson & Johnson Pipeline Embolization Device (PED) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Johnson & Johnson Pipeline Embolization Device (PED) Product Portfolio Table 118. Johnson & Johnson Recent Development Table 119. Stryker Corporation Company Information Table 120. Stryker Corporation Business Overview Table 121. Stryker Corporation Pipeline Embolization Device (PED) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Stryker Corporation Pipeline Embolization Device (PED) Product Portfolio Table 123. Stryker Corporation Recent Development Table 124. MicroPort Company Information Table 125. MicroPort Business Overview Table 126. MicroPort Pipeline Embolization Device (PED) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. MicroPort Pipeline Embolization Device (PED) Product Portfolio Table 128. MicroPort Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Pipeline Embolization Device (PED) Distributors List Table 132. Pipeline Embolization Device (PED) Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Pipeline Embolization Device (PED) Product Image Figure 2. Global Pipeline Embolization Device (PED) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pipeline Embolization Device (PED) Market Size (2021-2032) & (US$ Million) Figure 4. Global Pipeline Embolization Device (PED) Sales (2021-2032) & (k units) Figure 5. Global Pipeline Embolization Device (PED) Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pipeline Embolization Device (PED) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 48 Alloy Wire Braided Image Figure 9. 64 Alloy Wire Braided Image Figure 10. Other Image Figure 11. Global Pipeline Embolization Device (PED) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Pipeline Embolization Device (PED) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Pipeline Embolization Device (PED) Sales Market Share by Type (2021-2032) Figure 14. Global Pipeline Embolization Device (PED) Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Pipeline Embolization Device (PED) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Pipeline Embolization Device (PED) Revenue Market Share by Type (2021-2032) Figure 17. Intracranial Aneurysm Treatment Image Figure 18. Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.) Image Figure 19. Other Image Figure 20. Global Pipeline Embolization Device (PED) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Pipeline Embolization Device (PED) Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pipeline Embolization Device (PED) Sales Market Share by Application (2021-2032) Figure 23. Global Pipeline Embolization Device (PED) Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Pipeline Embolization Device (PED) Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pipeline Embolization Device (PED) Revenue Market Share by Application (2021-2032) Figure 26. North America Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Pipeline Embolization Device (PED) Sales Market Share by Country (2021-2032) Figure 28. U.S. Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Pipeline Embolization Device (PED) Sales Market Share by Country (2021-2032) Figure 33. Germany Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Pipeline Embolization Device (PED) Sales Market Share by Country (2021-2032) Figure 40. China Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Pipeline Embolization Device (PED) Sales Market Share by Country (2021-2032) Figure 48. Brazil Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Pipeline Embolization Device (PED) Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Pipeline Embolization Device (PED) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pipeline Embolization Device (PED) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Figure 59. North America Pipeline Embolization Device (PED) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pipeline Embolization Device (PED) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pipeline Embolization Device (PED) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pipeline Embolization Device (PED) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pipeline Embolization Device (PED) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pipeline Embolization Device (PED) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 48 Alloy Wire Braided
  • 64 Alloy Wire Braided
  • Other
Applications
  • Intracranial Aneurysm Treatment
  • Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
  • Other
Companies covered
  • Ascendis Health
  • Balt Extrusion
  • Boston Scientific
  • Codman
  • Evasc
  • Microvention
  • Phenox GmbH
  • Accumedical
  • ZYLOX-TONBRIDGE
  • Medtronic
  • Johnson & Johnson
  • Stryker Corporation
  • MicroPort

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pipeline Embolization Device (PED) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pipeline Embolization Device (PED) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pipeline Embolization Device (PED) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pipeline Embolization Device (PED) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pipeline Embolization Device (PED) Market Dynamics
  1. 2.1 Pipeline Embolization Device (PED) Industry Trends
  2. 2.2 Pipeline Embolization Device (PED) Industry Drivers
  3. 2.3 Pipeline Embolization Device (PED) Industry Opportunities and Challenges
  4. 2.4 Pipeline Embolization Device (PED) Industry Restraints
3 Pipeline Embolization Device (PED) Market by Manufacturers
  1. 3.1 Global Pipeline Embolization Device (PED) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pipeline Embolization Device (PED) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pipeline Embolization Device (PED) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pipeline Embolization Device (PED) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pipeline Embolization Device (PED) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pipeline Embolization Device (PED) Manufacturers, Product Type & Application
  7. 3.7 Global Pipeline Embolization Device (PED) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pipeline Embolization Device (PED) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pipeline Embolization Device (PED) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pipeline Embolization Device (PED) Tier 1, Tier 2, and Tier 3
4 Pipeline Embolization Device (PED) Market by Type
  1. 4.1 Pipeline Embolization Device (PED) Type Introduction
  2. 4.1.1 48 Alloy Wire Braided
  3. 4.1.2 64 Alloy Wire Braided
  4. 4.1.3 Other
  5. 4.2 Global Pipeline Embolization Device (PED) Sales by Type
  6. 4.2.1 Global Pipeline Embolization Device (PED) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pipeline Embolization Device (PED) Sales by Type (2021-2032)
  8. 4.2.3 Global Pipeline Embolization Device (PED) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Pipeline Embolization Device (PED) Revenue by Type
  10. 4.3.1 Global Pipeline Embolization Device (PED) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pipeline Embolization Device (PED) Revenue by Type (2021-2032)
  12. 4.3.3 Global Pipeline Embolization Device (PED) Revenue Market Share by Type (2021-2032)
5 Pipeline Embolization Device (PED) Market by Application
  1. 5.1 Pipeline Embolization Device (PED) Application Introduction
  2. 5.1.1 Intracranial Aneurysm Treatment
  3. 5.1.2 Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
  4. 5.1.3 Other
  5. 5.2 Global Pipeline Embolization Device (PED) Sales by Application
  6. 5.2.1 Global Pipeline Embolization Device (PED) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pipeline Embolization Device (PED) Sales by Application (2021-2032)
  8. 5.2.3 Global Pipeline Embolization Device (PED) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pipeline Embolization Device (PED) Revenue by Application
  10. 5.3.1 Global Pipeline Embolization Device (PED) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pipeline Embolization Device (PED) Revenue by Application (2021-2032)
  12. 5.3.3 Global Pipeline Embolization Device (PED) Revenue Market Share by Application (2021-2032)
6 Global Pipeline Embolization Device (PED) Sales by Region
  1. 6.1 Global Pipeline Embolization Device (PED) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pipeline Embolization Device (PED) Sales by Region (2021-2032)
  3. 6.2.1 Global Pipeline Embolization Device (PED) Sales by Region (2021-2026)
  4. 6.2.2 Global Pipeline Embolization Device (PED) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pipeline Embolization Device (PED) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pipeline Embolization Device (PED) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pipeline Embolization Device (PED) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pipeline Embolization Device (PED) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pipeline Embolization Device (PED) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pipeline Embolization Device (PED) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pipeline Embolization Device (PED) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pipeline Embolization Device (PED) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pipeline Embolization Device (PED) Revenue by Region
  1. 7.1 Global Pipeline Embolization Device (PED) Revenue by Region
  2. 7.1.1 Global Pipeline Embolization Device (PED) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pipeline Embolization Device (PED) Revenue by Region (2021-2026)
  4. 7.1.3 Global Pipeline Embolization Device (PED) Revenue by Region (2027-2032)
  5. 7.1.4 Global Pipeline Embolization Device (PED) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pipeline Embolization Device (PED) Revenue (2021-2032)
  8. 7.2.2 North America Pipeline Embolization Device (PED) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pipeline Embolization Device (PED) Revenue (2021-2032)
  11. 7.3.2 Europe Pipeline Embolization Device (PED) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pipeline Embolization Device (PED) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pipeline Embolization Device (PED) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pipeline Embolization Device (PED) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pipeline Embolization Device (PED) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Ascendis Health
  2. 8.1.1 Ascendis Health Company Information
  3. 8.1.2 Ascendis Health Business Overview
  4. 8.1.3 Ascendis Health Pipeline Embolization Device (PED) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ascendis Health Pipeline Embolization Device (PED) Product Portfolio
  6. 8.1.5 Ascendis Health Recent Developments
  7. 8.2 Balt Extrusion
  8. 8.2.1 Balt Extrusion Company Information
  9. 8.2.2 Balt Extrusion Business Overview
  10. 8.2.3 Balt Extrusion Pipeline Embolization Device (PED) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Balt Extrusion Pipeline Embolization Device (PED) Product Portfolio
  12. 8.2.5 Balt Extrusion Recent Developments
  13. 8.3 Boston Scientific
  14. 8.3.1 Boston Scientific Company Information
  15. 8.3.2 Boston Scientific Business Overview
  16. 8.3.3 Boston Scientific Pipeline Embolization Device (PED) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boston Scientific Pipeline Embolization Device (PED) Product Portfolio
  18. 8.3.5 Boston Scientific Recent Developments
  19. 8.4 Codman
  20. 8.4.1 Codman Company Information
  21. 8.4.2 Codman Business Overview
  22. 8.4.3 Codman Pipeline Embolization Device (PED) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Codman Pipeline Embolization Device (PED) Product Portfolio
  24. 8.4.5 Codman Recent Developments
  25. 8.5 Evasc
  26. 8.5.1 Evasc Company Information
  27. 8.5.2 Evasc Business Overview
  28. 8.5.3 Evasc Pipeline Embolization Device (PED) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Evasc Pipeline Embolization Device (PED) Product Portfolio
  30. 8.5.5 Evasc Recent Developments
  31. 8.6 Microvention
  32. 8.6.1 Microvention Company Information
  33. 8.6.2 Microvention Business Overview
  34. 8.6.3 Microvention Pipeline Embolization Device (PED) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Microvention Pipeline Embolization Device (PED) Product Portfolio
  36. 8.6.5 Microvention Recent Developments
  37. 8.7 Phenox GmbH
  38. 8.7.1 Phenox GmbH Company Information
  39. 8.7.2 Phenox GmbH Business Overview
  40. 8.7.3 Phenox GmbH Pipeline Embolization Device (PED) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Phenox GmbH Pipeline Embolization Device (PED) Product Portfolio
  42. 8.7.5 Phenox GmbH Recent Developments
  43. 8.8 Accumedical
  44. 8.8.1 Accumedical Company Information
  45. 8.8.2 Accumedical Business Overview
  46. 8.8.3 Accumedical Pipeline Embolization Device (PED) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Accumedical Pipeline Embolization Device (PED) Product Portfolio
  48. 8.8.5 Accumedical Recent Developments
  49. 8.9 ZYLOX-TONBRIDGE
  50. 8.9.1 ZYLOX-TONBRIDGE Company Information
  51. 8.9.2 ZYLOX-TONBRIDGE Business Overview
  52. 8.9.3 ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Product Portfolio
  54. 8.9.5 ZYLOX-TONBRIDGE Recent Developments
  55. 8.10 Medtronic
  56. 8.10.1 Medtronic Company Information
  57. 8.10.2 Medtronic Business Overview
  58. 8.10.3 Medtronic Pipeline Embolization Device (PED) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Medtronic Pipeline Embolization Device (PED) Product Portfolio
  60. 8.10.5 Medtronic Recent Developments
  61. 8.11 Johnson & Johnson
  62. 8.11.1 Johnson & Johnson Company Information
  63. 8.11.2 Johnson & Johnson Business Overview
  64. 8.11.3 Johnson & Johnson Pipeline Embolization Device (PED) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Johnson & Johnson Pipeline Embolization Device (PED) Product Portfolio
  66. 8.11.5 Johnson & Johnson Recent Developments
  67. 8.12 Stryker Corporation
  68. 8.12.1 Stryker Corporation Company Information
  69. 8.12.2 Stryker Corporation Business Overview
  70. 8.12.3 Stryker Corporation Pipeline Embolization Device (PED) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Stryker Corporation Pipeline Embolization Device (PED) Product Portfolio
  72. 8.12.5 Stryker Corporation Recent Developments
  73. 8.13 MicroPort
  74. 8.13.1 MicroPort Company Information
  75. 8.13.2 MicroPort Business Overview
  76. 8.13.3 MicroPort Pipeline Embolization Device (PED) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 MicroPort Pipeline Embolization Device (PED) Product Portfolio
  78. 8.13.5 MicroPort Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pipeline Embolization Device (PED) Value Chain Analysis
  2. 9.1.1 Pipeline Embolization Device (PED) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pipeline Embolization Device (PED) Production Mode & Process
  6. 9.2 Pipeline Embolization Device (PED) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pipeline Embolization Device (PED) Distributors
  9. 9.2.3 Pipeline Embolization Device (PED) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst